Alpha-1-antichymotrypsin (AACT) is a plasma protease inhibitor and member of the serine protease inhibitor class (SERPIN). AACT polymorphism is tissue specific and influences protease targeting. Variation in AACT sequence has been implicated in Alzheimer's disease, and activity deficiency has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease.
克隆类型:
Rabbit Polyclonal Antibody
亚型:
Rabbit Ig
免疫原:
KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human AACT.